• Mashup Score: 2

    Drs. Michael Chiang, R. V. Paul Chan, and J. Peter Campbell, members of the Imaging and Informatics in Retinopathy of Prematurity (i-ROP) Research Consortium, discuss the latest advances in ROP screen

    Tweet Tweets with this article
    • Experts InSIght: @NEIDirector @rvpchan and @jpetercampbell join Ben Young to discuss the latest advances in #retinopathy of prematurity (#ROP) screening, treatment and management. #pediatrics #retina #ophthalmology https://t.co/elv2uVduJt https://t.co/XScKgMW87b

  • Mashup Score: 0

    Objective This study aimed to evaluate the preference for antivascular endothelial growth factor (anti-VEGF) versus laser ablation therapy as primary and additional treatment in aggressive retinopathy of prematurity (ROP) and type 1 ROP. Methods This multicentre retrospective study was conducted at nine medical centres across South Korea. A total of 94 preterm infants with ROP who underwent…

    Tweet Tweets with this article
    • New study shows that #South Korea preference for #antiVEGF vs #laserablation therapy for #ROP treatment varies by ROP subtype, zone, and primary/secondary treatment. Findings emphasize the importance of personalized ROP management. https://t.co/nucWOOq4zb #pediatrics https://t.co/KDSi3khw3m

  • Mashup Score: 0
    ROP Protection - 1 year(s) ago

    A nanoparticle based therapy for retinopathy of prematurity

    Tweet Tweets with this article
    • This #WorldPrematurityDay, @Geoff3P writes about a nanoparticle-based therapeutic that prevents #ROP with a single injection, allowing for healthy #retinal development #retinopathyofprematurity #prematurity https://t.co/9EtOijA2vI

  • Mashup Score: 0

    Gurus of ophthalmic AI – Linda Zangwill, Michael F. Chiang, and Damien Gatinel – consider where and how the technology can help deliver the highest quality eye care

    Tweet Tweets with this article
    • Here, @NEIDirector Michael F. Chiang, considers how #ROP is a promising area for medical devices based on #artificialintelligence #AI (scroll down to the relevant part) https://t.co/0TtXwxeR1q

  • Mashup Score: 1

    Editorial BoardPublished in issue: December 2022A3PDF ContentsPublished in issue: December 2022A5PDF This Issue at a GlanceSandeep RavindranPublished in issue: December 2022p1335Full-Text HTMLPDF A Simple Vista en Este NúmeroSandeep RavindranPublished in issue: December 2022e1-e2Full-Text HTMLPDF 期刊一览Sandeep RavindranPublished in…

    Tweet Tweets with this article
    • Ophthalmology's December issue is now online! Featuring Primary Tube Versus Trabeculectomy Study after 5 years of follow-up, treatment of Charles Bonnet syndrome, meta-analysis of retreatment rates in #ROP, iris and ciliary body melanocytomas & more! https://t.co/fy4Jdq1A1C https://t.co/2a6WYnLNgN

  • Mashup Score: 3

    Retinopathy of prematurity expert C. Armitage Harper, III, MD, of the Austin Retina Associates in Austin, Texas, discusses his experience in treating ROP cases across the globe, and his mission to prevent pre-term blindness in infants.

    Tweet Tweets with this article
    • #PODCAST: Retinopathy of prematurity expert C. Armitage Harper, III, MD, discusses his global mission to prevent pre-term #blindness in infants. LISTEN HERE: https://t.co/v7THKwoSxc #Ophthalmology #retina #ROP #pediatrics https://t.co/iw9ySSNLQJ

  • Mashup Score: 2

    Luis Acaba-Berrocal, MD, of the Illinois Eye and Ear Infirmary in Chicago, worked with a group of colleagues to conduct a multicenter, retrospective, consecutive study of infants with ROP who had been treated with intravitreal anti-VEGF injections between 2008 and 2020 in light of the dearth of real-world data on the topic.

    Tweet Tweets with this article
    • Intravitreal injections for #ROP prove safe, effective in many cases. Read: https://t.co/3jZKlhgU30 #Ophthalmology #Pediatrics #Therapeutics https://t.co/fpyIJPn3ti